Fig. 1From: Mesenchymal stem cells combined with liraglutide relieve acute lung injury through apoptotic signaling restrained by PKA/β-cateninAnimal experiment flow chart. Human chorionic villus-derived mesenchymal stem cells (hCMSCs), human bone marrow-derived mesenchymal stem cells (hBMSCs), human adipose-derived mesenchymal stem cells (hAMSCs), and bronchoalveolar lavage fluid (BALF)Back to article page